Join
Live feed
·
PRReleasevia Quantisnow
Lineage Cell Therapeutics Inc. logo

Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

ByQuantisnow·Wall Street's wire, on your screen.
LCTX· Lineage Cell Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LCTX (Lineage Cell Therapeutics Inc.) and more on Quantisnow.